Efficacy and safety of Sangbaipi Decoction in patients with acute exacerbation of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Efficacy and safety of Sangbaipi Decoction in patients with acute exacerbation of chronic obstructive pulmonary disease

Published:2020-10-30 Issue:44 Volume:99 Page:e22917
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Jiazhou,Jiang Junlin,Jing Chunxiang,Zheng Wenjiang,Pan Huashan

Funder

research project of Guangzhou University of Chinese Medicine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference21 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: gold executive summary;Vogelmeier;Eur Respir J,2017

2. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study;Wang;Lancet,2018

3. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China;Cai;Int J Chron Obstruct Pulmon Dis,2014

4. Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD);Adcock;Curr Pharm Des,2010

5. Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis;Liu;BMC Complement Altern Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Pharmacology Followed by Experimental Validation to Explore the Mechanism of Stigmasterol in Sangbaipi Decoction Regulating PI3K/Akt Signaling to Alleviate Acute Exacerbation of Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2024-08

2. Analysis of the Effects of Humidified High Flow Nasal Oxygen Therapy Combined with Noninvasive Mechanical Ventilation on Treatment Outcomes;Computational Intelligence and Neuroscience;2022-04-10